These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12070863)

  • 1. [Atypical neuroleptics--a heterogenous group. Valuable option in acute psychoses].
    MMW Fortschr Med; 2002 May; Suppl 2():85. PubMed ID: 12070863
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotic medications and the treatment of schizophrenia.
    Lewis DA
    Am J Psychiatry; 2002 Feb; 159(2):177-9. PubMed ID: 11823256
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on amisulpride.
    Green B
    Curr Med Res Opin; 2002; 18(3):113-7. PubMed ID: 12094819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia.
    Lecrubier Y; Azorin M; Bottai T; Dalery J; Garreau G; Lempérière T; Lisoprawski A; Petitjean F; Vanelle JM
    Neuropsychobiology; 2001; 44(1):41-6. PubMed ID: 11408792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended.
    Leucht S; Busch R; Hamann J; Kissling W; Kane JM
    Biol Psychiatry; 2005 Jun; 57(12):1543-9. PubMed ID: 15953491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M; Scheel T; Eich FX
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotic agents: what do meta analyses say?].
    Millet B
    Encephale; 2007 Jun; 33 Pt 3():S419-24. PubMed ID: 19101363
    [No Abstract]   [Full Text] [Related]  

  • 10. Zuclopenthixol dihydrochloride for schizophrenia.
    Kumar A; Strech D
    Schizophr Bull; 2009 Sep; 35(5):855-6. PubMed ID: 19661197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Solian: evaluation of 10 years' experimentation and clinical practice].
    Baldauf A; Metzger JY; Sichel JP
    Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244
    [No Abstract]   [Full Text] [Related]  

  • 12. Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
    Darcourt G
    Acta Psychiatr Scand Suppl; 2000; 400():5-6. PubMed ID: 10823304
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
    Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
    Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of positive and negative symptoms: pharmacologic approaches.
    Boyer P; Lecrubier Y; Puech AJ
    Mod Probl Pharmacopsychiatry; 1990; 24():152-74. PubMed ID: 1970852
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 16. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amisulpride--a neuroleptic agent for all phases of schizophrenia].
    Nervenarzt; 1999 Mar; 70(3 Suppl Amisulprid):1-8. PubMed ID: 10221135
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].
    Strasser O; Schmauss M; Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S38-40. PubMed ID: 15570496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.